Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Cot/Tpl-2 Protein Kinase as a Target for the Treatment of Inflammatory Disease

Author(s): D. George and A. Salmeron

Volume 9, Issue 7, 2009

Page: [611 - 622] Pages: 12

DOI: 10.2174/156802609789007345

Price: $65

Abstract

Cot/Tpl-2/MAP3K8 is a serine/threonine protein kinase that is essential for lipopolysaccharide (LPS)-induced activation of the MEK/ERK pathway in macrophages as demonstrated in Cot/Tpl-2-deficient mice. Cot/Tpl-2 kinase activation plays an integral role in the production of pro-inflammatory cytokines such as TNF and IL-1β in this immune cell type. Elevated levels of these cytokines have been clinically implicated as mediators of a number of autoimmune diseases, in particular, the pain and joint destruction of rheumatoid arthritis. By inference, pharmaceutical agents that inhibit Cot/Tpl-2 kinase have the potential to be novel and effective therapies for the treatment of these diseases. This review will describe the physiological regulation and importance of Cot/Tpl-2 in inflammation as well as the landscape of small molecules that have been reported as Cot/Tpl-2 inhibitors.

Keywords: Cot/Tpl-2, serine/threonine kinase, LPS, macrophages, kinase inhibitors


Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy